PRACTICE ALERT PODCAST
Audio

Why you shouldn’t screen for ovarian cancer in asymptomatic women

J Fam Pract. 2018 April;67(4):audio
By
Doug Campos-Outcalt, MD, MPA
Author and Disclosure Information

In this audiocast, Doug Campos-Outcalt, MD, MPA, explains why the US Preventive Services Task Force has reaffirmed its 2012 recommendation against screening asymptomatic women for ovarian cancer.

 

Resources

  1. US Preventive Services Task Force. Screening for ovarian cancer: US Preventive Services Task Force Recommendation Statement. JAMA. 2018;319:588-594.
  2. Henderson JT, Webber EM, Sawaya GF. Screening for ovarian cancer: updated evidence report and systematic review for the US Preventive Services Task Force. JAMA. 2018;319:595-606.

Recommended Reading

Interventions urged to stop rising NAS, stem Medicaid costs
MDedge Family Medicine
Same-day discharge for hysterectomy
MDedge Family Medicine
FDA approves certolizumab label update for pregnancy, breastfeeding
MDedge Family Medicine
Axial SpA disease activity remains mostly stable throughout pregnancy
MDedge Family Medicine
Efavirenz-based ART may hamper vaginal ring contraception
MDedge Family Medicine
Here’s one issue blue and red states agree on: Preventing deaths of expectant and new mothers
MDedge Family Medicine
Sexual harassment, violence is our problem, too
MDedge Family Medicine
Sling revisions: pain as indication linked with SUI recurrence
MDedge Family Medicine
MDedge Daily News: Why most heart failure may be preventable
MDedge Family Medicine
MDedge Daily News: Can androgen therapy improve male frailty?
MDedge Family Medicine